Display options
Share it on

World J Hepatol. 2017 Mar 28;9(9):477-486. doi: 10.4254/wjh.v9.i9.477.

Characteristics of escape mutations from occult hepatitis B virus infected patients with hematological malignancies in South Egypt.

World journal of hepatology

Abeer Elkady, Sayuki Iijima, Sahar Aboulfotuh, Elsayed Mostafa Ali, Douaa Sayed, Nashwa M Abdel-Aziz, Amany M Ali, Shuko Murakami, Masanori Isogawa, Yasuhito Tanaka

Affiliations

  1. Abeer Elkady, Department of Clinical and Chemical Pathology, Medical School of South Valley University, Qena 83523, Egypt.

PMID: 28396718 PMCID: PMC5368625 DOI: 10.4254/wjh.v9.i9.477

Abstract

AIM: To investigate the prevalence and virological characteristics of occult hepatitis B virus (HBV) infections in patients with hematological malignancies in South Egypt.

METHODS: Serum samples were collected from 165 patients with hematological malignancies to monitor titers of HBV DNA, hepatitis B surface antigen (HBsAg), and antibodies to HBV core (anti-HBc) and surface antigens. Serum samples negative for HBsAg and positive for anti-HBc were subjected to nucleic acid extraction and HBV DNA detection by real-time polymerase chain reaction. DNA sequences spanning the S region were analyzed in cases with occult HBV infection.

RESULTS: HBV DNA was detected in 23 (42.6%) of 54 patients with hematological malignancies who were HBsAg negative, but anti-HBc positive, suggesting the presence of occult HBV infection. The complete HBV genome was retrieved from 6 occult HBV patients, and P120T and S143L were detected in 3 and 2 cases, respectively. Site directed mutagenesis was done to produce 1.24-fold genotype D clones with amino acid mutations T120 and L143. The

CONCLUSION: Occult HBV infection is common in patients with hematological malignancies and associated with P120T and S143L mutations. 120T mutation impairs the detection of HBsAg by CLEIA.

Keywords: Escape mutation; Hematological malignancies; Occult hepatitis B infection

Conflict of interest statement

Conflict-of-interest statement: Authors do not have any financial or personal relationship with other people or organizations that could inappropriately influence their work.

References

  1. Hepatology. 2006 Oct;44(4):915-24 - PubMed
  2. J Virol. 2005 Nov;79(22):14404-10 - PubMed
  3. Liver Int. 2014 Jul;34(6):e144-50 - PubMed
  4. J Hepatol. 2015 Sep;63(3):546-53 - PubMed
  5. J Hepatol. 2007 Jan;46(1):160-70 - PubMed
  6. World J Gastroenterol. 2011 Mar 28;17(12):1558-62 - PubMed
  7. J Viral Hepat. 2010 Aug;17(8):588-97 - PubMed
  8. J Gastroenterol. 2003;38(3):244-53 - PubMed
  9. Virol J. 2014 Jan 21;11:9 - PubMed
  10. Liver Int. 2009 Apr;29(4):518-24 - PubMed
  11. Hepatol Int. 2008 Jun;2(2):152-62 - PubMed
  12. J Med Virol. 2012 Apr;84(4):587-95 - PubMed
  13. World J Gastroenterol. 2013 Oct 7;19(37):6214-20 - PubMed
  14. J Hepatol. 2012 Oct;57(4):720-9 - PubMed
  15. Hepatology. 2006 Aug;44(2):326-34 - PubMed
  16. World J Gastroenterol. 2011 Mar 28;17(12):1529-30 - PubMed
  17. PLoS One. 2013 Aug 12;8(8):e70768 - PubMed
  18. Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):1997-2001 - PubMed
  19. J Med Virol. 2004 Aug;73(4):508-15 - PubMed
  20. World J Gastroenterol. 2015 Feb 14;21(6):1794-803 - PubMed
  21. J Hepatol. 2008 Jun;48(6):1022-5 - PubMed
  22. J Viral Hepat. 2012 Oct;19(10):716-23 - PubMed
  23. J Virol. 2002 Jun;76(12):5985-92 - PubMed
  24. J Gastroenterol. 2009;44(4):359-64 - PubMed
  25. Blood Transfus. 2014 Jan;12 Suppl 1:s63-8 - PubMed
  26. World J Hepatol. 2013 Feb 27;5(2):64-73 - PubMed
  27. J Viral Hepat. 2016 Dec;23 (12 ):1027-1035 - PubMed
  28. J Biol Regul Homeost Agents. 2012 Jul-Sep;26(3):457-65 - PubMed
  29. Gut. 2000 Sep;47(3):429-35 - PubMed
  30. Trop Gastroenterol. 2012 Oct-Dec;33(4):242-50 - PubMed
  31. World J Hepatol. 2015 Jun 28;7(12):1671-8 - PubMed
  32. Antiviral Res. 2012 Jan;93(1):86-93 - PubMed
  33. J Virol. 2010 Dec;84(24):12850-61 - PubMed
  34. Nephrol Dial Transplant. 2006 Apr;21(4):1046-52 - PubMed
  35. Med Microbiol Immunol. 2013 Jun;202(3):207-14 - PubMed
  36. Hepatology. 2004 Nov;40(5):1053-61 - PubMed
  37. Hepat Mon. 2011 Sep;11(9):714-8 - PubMed
  38. J Viral Hepat. 1999 Jan;6(1):73-8 - PubMed
  39. Lancet. 1990 Aug 11;336(8711):325-9 - PubMed
  40. J Med Virol. 2015 Feb;87(2):199-207 - PubMed
  41. J Med Virol. 2003 Aug;70(4):529-36 - PubMed
  42. Vox Sang. 1989;56(1):63 - PubMed
  43. PLoS One. 2015 Jul 06;10(7):e0131912 - PubMed
  44. J Clin Microbiol. 2010 Feb;48(2):357-62 - PubMed
  45. Gastroenterology. 2009 Feb;136(2):652-62.e3 - PubMed
  46. J Hepatol. 2008 Oct;49(4):537-47 - PubMed
  47. J Med Virol. 2011 Mar;83(3):412-8 - PubMed
  48. J Clin Virol. 2009 Sep;46(1):101-3 - PubMed
  49. Hepatol Res. 2008 Mar;38(3):234-43 - PubMed
  50. Arch Virol. 1998;143(12):2313-26 - PubMed
  51. Eur J Clin Microbiol Infect Dis. 2015 Sep;34(9):1709-31 - PubMed

Publication Types